George Kelly Martin - 10 Aug 2023 Form 3/A Insider Report for TriSalus Life Sciences, Inc. (TLSI)

Role
Director
Signature
/s/ Sean Murphy, Attorney-in-Fact
Issuer symbol
TLSI
Transactions as of
10 Aug 2023
Net transactions value
$0
Form type
3/A
Filing time
21 May 2024, 17:38:17 UTC
Date Of Original Report
14 Aug 2023
Next filing
21 Aug 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding TLSI Common Stock 247,185 10 Aug 2023 By Varka LLC F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were inadvertently omitted from the Reporting Person's original Form 3.
F2 The securities reported herein were acquired by the Reporting Person prior to the Reporting Person becoming a director of the Issuer. The Reporting Person was appointed as a director of the Issuer effective immediately after the effective time of the Merger (as defined in that certain Agreement and Plan of Merger, dated as of November 11, 2022, as amended, by and among the Issuer, MTAC Merger Sub, Inc., and TriSalus Operating Life Sciences, Inc.).
F3 The shares are held by Varka LLC. The Reporting Person may be deemed to have beneficial ownership of the shares held directly by Varka LLC.